Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
2 participants
INTERVENTIONAL
2014-08-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Motion Analysis in Children With MRI
NCT00367354
MRI for Non-Invasive Imaging in Neonates and Children
NCT02163681
Normal Liver Stiffness by MR Elastography
NCT03235414
Pediatric Radio Frequency Coils Generic
NCT01633866
The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients
NCT04284371
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI with MRE
Magnetic Resonance Imaging with Magnetic Resonance Elastography using the GE MR Touch device
MRI with MRE
Magnetic Resonance Imaging with Magnetic Resonance Elastography using the GE MR Touch device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI with MRE
Magnetic Resonance Imaging with Magnetic Resonance Elastography using the GE MR Touch device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Known liver disease based (liver enzymes, bilirubin, and/or GGT at least twice the upper limit of normal for age)
* Parental/LAR permission obtained
Exclusion Criteria
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital Medical Center, Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie Merhar, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Medical Center, Cincinnati
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-3065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.